The agency has already contacted the Ministry of Health, which gave the guidance to leave the entire load ‘in quarantine’ until it is analyzed by the National Institute of Quality Control in Health (INCQS)
A Federal District Health Department reported this Saturday, 3, that he received 40,100 doses of Janssen’s vaccine against a Covid-19 stored irregularly. In a statement, the folder claimed that the immunizing agent arrived “frozen” and thus “unavailable for use” at the time. The agency has already contacted the Ministry of Health, which passed the guidance to leave the entire cargo “in quarantine”. Thus, it will be analyzed by the National Institute of Quality Control in Health (INCQS) next Monday, 5, to assess whether the doses can still be applied in the local population.
The finding happened this morning during the conference of doses at the Central Cold Chain, which stores and distributes vaccines in the capital. In a statement, the Health Department of the Federal District found that Janssen’s vaccines, which require only one application per person, were below the appropriate temperature for this immunizing agent, 2°C. It is worth remembering that the Federal District reached the mark of 1,005,782 people immunized against the new coronavirus on Friday, 2 – the number is equivalent to 32.46% of the population.
Check out the full note below:
The Federal District received, this morning (3), 40,100 doses of the Janssen vaccine. However, at the time of the conference at the Central Cold Chain, it was observed that the vaccines were frozen, below the appropriate temperature for this immunizing agent, which is 2°C. Thus, the Ministry of Health has already been activated by the Department of Health and the orientation of the federal agency is to leave the entire load of vaccines in quarantine. They will be stored and unavailable for use at the time.
The Ministry said that on Monday (5) will request quality analysis by the National Institute of Quality Control in Health (INCQS) to verify the stability of immunobiologicals and whether it is safe to apply these vaccines.